{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:54:26Z","timestamp":1793620466404,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>There are limited data on the outcome of transplant recipients with familial Mediterranean fever (FMF)-associated AA amyloidosis. The aim of the present study is to evaluate demographic, clinical, laboratory, and prognostic characteristics and outcome measures of these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Eighty-one renal transplant recipients with FMF-associated AA amyloidosis (group 1) and propensity score\u2013matched transplant recipients (group 2, n = 81) with nonamyloidosis etiologies were evaluated in this retrospective, multicenter study. Recurrence of AA amyloidosis was diagnosed in 21 patients (group 1a), and their features were compared with 21 propensity score\u2013matched recipients with FMF amyloidosis with no laboratory signs of recurrence (group 1b).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      The risk of overall allograft loss was higher in group 1 compared with group 2 (25 [30.9%] versus 12 [14.8%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.015 [hazard ratio, 2.083; 95% confidence interval, 1.126-3.856]). Patients in group 1 were characterized by an increased risk of mortality compared with group 2 (11 [13.6%] versus 0%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001 [hazard ratio, 1.136; 95% confidence interval, 1.058-1.207]). Kaplan-Meier analysis revealed that 5- and 10-year patient survival rates in group 1 (92.5% and 70.4%) were significantly lower than in group 2 (100% and 100%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.026 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.023, respectively). Although not reaching significance, overall, 5- and 10-year graft survival rates (57.1%, 94.7%, and 53.8%, respectively) in group 1a were worse than in group 1b (76.2%, 95%, and 77.8%, respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.19,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.95, and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.27, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>AA amyloidosis is associated with higher risk of mortality after kidney transplantation. Inflammatory indicators should be monitored closely, and persistent high levels of acute-phase reactants should raise concerns about amyloid recurrence in allograft.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000003043","type":"journal-article","created":{"date-parts":[[2019,11,4]],"date-time":"2019-11-04T14:18:50Z","timestamp":1572877130000},"page":"1703-1711","source":"Crossref","is-referenced-by-count":14,"title":["Amyloid A Amyloidosis After Renal Transplantation: An Important Cause of Mortality"],"prefix":"10.1097","volume":"104","author":[{"given":"Irem","family":"Sarihan","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasar","family":"Caliskan","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."},{"name":"Division of Nephrology and Hypertension, Saint Louis University School of Medicine, Saint Louis, MO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safak","family":"Mirioglu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Ozluk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Senates","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurhan","family":"Seyahi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taner","family":"Basturk","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Sisli Hamidiye Etfal Training and Education Hospital, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmecit","family":"Yildiz","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Uludag University Faculty of Medicine, Bursa, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isin","family":"Kilicaslan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Sukru","family":"Sever","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1523-1755.2004.00485.x","article-title":"Renal amyloidosis in familial Mediterranean fever.","volume":"65","author":"Ozen","year":"2004","journal-title":"Kidney Int"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial Mediterranean fever in the world.","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","article-title":"Hereditary periodic fever and reactive amyloidosis.","volume":"5","author":"van der Hilst","year":"2005","journal-title":"Clin Exp Med"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis.","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1016\/j.transproceed.2013.09.021","article-title":"Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience.","volume":"45","author":"Abedi","year":"2013","journal-title":"Transplant Proc"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis.","volume":"42","author":"Sherif","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1600-6143.2011.03620.x","article-title":"Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study.","volume":"11","author":"Kofman","year":"2011","journal-title":"Am J Transplant"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1097\/TP.0000000000001681","article-title":"Familial Mediterranean fever is associated with increased mortality after kidney transplantation-A 19 years\u2019 single center experience.","volume":"101","author":"Green","year":"2017","journal-title":"Transplantation"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/TP.0000000000001930","article-title":"Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis.","volume":"102","author":"Sawinski","year":"2018","journal-title":"Transplantation"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-6419.2007.00527.x","article-title":"Some practical guidance for the implementation of propensity score matching.","volume":"22","author":"Caliendo","year":"2008","journal-title":"J Econ Surv"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ndt\/gfs492","article-title":"End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.","volume":"28","author":"Tang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R16-20231002","first-page":"375","article-title":"Transplantation in renal amyloidosis.","volume":"12","author":"T\u00fcrkmen","year":"1998","journal-title":"Clin Transplant"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/S0041-1345(01)02461-7","article-title":"Renal transplantation in amyloidosis secondary to familial Mediterranean fever.","volume":"33","author":"Sever","year":"2001","journal-title":"Transplant Proc"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5301\/ijao.5000091","article-title":"Outcome of patients with amyloidosis after renal transplantation: a single-center experience.","volume":"35","author":"Gursu","year":"2012","journal-title":"Int J Artif Organs"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.transproceed.2016.04.015","article-title":"Comparative analysis of outcomes of kidney transplantation in patients with AA amyloidosis and chronic glomerulonephritis.","volume":"48","author":"Sahutoglu","year":"2016","journal-title":"Transplant Proc"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"R21-20231002","first-page":"317","article-title":"Serum amyloid A protein and C-reactive protein in systemic amyloidosis.","volume":"3","author":"Gertz","year":"1985","journal-title":"Clin Exp Rheumatol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2362.1995.tb01739.x","article-title":"Albumin affects erythrocyte aggregation and sedimentation.","volume":"25","author":"Reinhart","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000186801","article-title":"Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever.","volume":"60","author":"Livneh","year":"1992","journal-title":"Nephron"},{"key":"R24-20231002","first-page":"50","article-title":"Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo.","volume":"261","author":"Speeg","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-20231002","first-page":"75","article-title":"Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature.","volume":"10","author":"van der Hilst","year":"2016","journal-title":"Biologics"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/tri.13312","article-title":"Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis.","volume":"31","author":"\u00d6z\u00e7akar","year":"2018","journal-title":"Transpl Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:25:06Z","timestamp":1696209906000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003043","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,30]]}}}